BRIEF-Eleven Biotherapeutics Q2 loss per share $0.30
Aug 14 (Reuters) - Eleven Biotherapeutics Inc
* Eleven Biotherapeutics reports second quarter 2017 financial results
* Q2 loss per share $0.30
* Eleven Biotherapeutics Inc - expects to have cash to fund research and development programs and operations into early 2018. Source text for Eikon: Further company coverage: